Long-term Remission of Wells Syndrome With Omalizumab
Coattrenec Y1, Ibrahim Yasmine L2, Harr T1, Spoerl D1*, Jandus P1*
1Division of Immunology and Allergology, Department of Internal Medicine, University Hospital and Medical Faculty, Geneva, Switzerland
2Division of Clinical Pathology, University Hospital and Medical Faculty, Geneva, Switzerland
*DS and PJ contributed equally to this work.
J Investig Allergol Clin Immunol 2020; Vol 30(1)
Key words: Wells syndrome, Eosinophilic cellulitis, Omalizumab, Successful treatment